By Mike Stobbe
A month after federal officials recommended new versions of COVID-19 vaccines, 7% of U.S. adults and 2% of children have gotten a shot.
One expert called the rates “abysmal.”
The numbers, presented Thursday at a meeting held by the Centers for Disease Control and Prevention, come from a national survey of thousands of Americans, conducted two weeks ago.
The data also indicated that nearly 40% of adults said they probably or definitely will not get the shot. A similar percentage of parents said they did not plan to vaccinate their children.
In the late summer, government health officials made the nation's COVID-19 vaccination campaign more like the annual flu campaign.
Officials approved updated shots that have a single target, an omicron descendant named XBB.1.5. They replaced vaccines that targeted the original coronavirus strain and a much earlier omicron version. Last month, the CDC recommended the new shots for everyone 6 months and older.
The government also transitioned to a commercialized system that relied on the health-care industry — not the government — to handle the distribution of the shots. Many people who immediately went for shots said pharmacies or doctors didn't have them.
Americans have been urged to get different iterations of the vaccines for more than 2/12 years. This year, COVID-19 deaths and hospitalizations fell to lower levels than seen in the previous three years.
Cases remain low compared with the pandemic's early months. Even so, health officials say about 18,000 hospitalization and 1,200 deaths are still being reported each week.
One expert at the meeting, Dr. Camille Kotton of Harvard Medical School, called the numbers “abysmal” and said part of the problem may be patient confusion. She urged stepped-up public education efforts.
Dr. David Kimberlin, of the University of Alabama at Birmingham, also expressed dismay.
“The recommendations are not being heard," he said.
The theme of Bill and Melinda Gates' annual letter for 2019 is "surprise." The letter, released Tuesday, acts as a roadmap for how the Gates Foundation plans to invest in technology that will help make the world a better place in the years to come. And, as Melinda Gates told Cheddar in an interview, it starts with poop.
There's a dearth of research to back up the abundance of miraculous health claims tied to CBD ー but that won't stop celebrities from endorsing it. CBD, or cannabidiol, is a component of cannabis or hemp with little to no psychotropic effects. It is purported to have an array of applications to treat everything from epilepsy to anxiety, pain, depression, and sleeplessness. When Congress and President Trump signed the latest version of the Farm Bill into effect, they also legalized hemp, and thereby CBD derived from hemp.
More than 50 years after the psychedelic Summer of Love, psilocybin, the psychoactive component in magic mushrooms, is having a moment. Researchers at leading universities have been conducting research on the purported medical benefits of mushrooms for years, but as studies yield promising results, the opioid epidemic persists and sentiment warms toward cannabis, mushrooms are earning a lot more attention. Lawmakers and psychotropic advocates have concurrently advanced separate measures in Oregon, Colorado, and, most recently, Iowa, that attempt to loosen restrictions on these hallucinogenic fungi.
These are the headlines you Need 2 Know for Thursday, Feb. 7, 2019.
These are the headlines you Need 2 Know for Wednesday, Feb, 6, 2019.
Millions of people around the world are getting ready for the Super Bowl on Sunday. And while the day is all fun and games, there's still a serious discussion happening about player safety. Now, two leading sports brands have teamed up to design new, state-of-the-art equipment using 3D printing. Joe DeSimone, co-founder and CEO of Carbon, stopped by Cheddar with more on how technology is making football more safe, head to toe.
These are the headlines you Need 2 Know for Friday, Feb. 1, 2019.
These are the headlines you Need 2 Know for Wednesday, Jan. 30, 2019.
Canopy Growth is planning its entry to the U.S. on the back of the new Farm Bill ー and aims to establish a hemp "hub" in New York, according to CEO Bruce Linton."New York is setting up a pretty progressive approach and we have an earlier first license under that system so we can actually create a hub," Linton told Cheddar on Tuesday.
Meditation app Headspace is zen about its future. Coming off a profitable year in 2018, with more than $100 million in revenue, CEO and co-founder Rich Pierson told Cheddar on Monday that the company is looking to continue its domination of the digital meditation space by pushing into healthcare and international markets.
